Microdosing
GUIDE & BENEFITS

Canadian users have identified 125 mg as their preferred dose of magic mushrooms. However, should you find the initial effects too intense, it’s advisable to scale back to 75 mg. Conversely, if the effects are not immediately noticeable, experimenting with a dosage of 250 mg or higher is an option. Remember, it’s crucial to allow yourself ample time for exploration and avoid comparing your dosage to others’. Ultimately, prioritize what feels most comfortable and effective for your individual experience.

Microdosing is intended to subtly enhance your normal state, akin to feeling like yourself but on a particularly good day. Typically, the immediate effects last for 4 to 6 hours, with many users reporting a pleasant “afterglow” the following day. On dose days, the effects are subtle yet noticeable, allowing individuals to carry out their daily activities without impairment. Common experiences include heightened appreciation for music, increased empathy, enhanced energy levels, improved focus, and heightened awareness of surroundings, especially nature.

During non-dose days, many microdosers continue to experience the afterglow, with introspective effects often extending into the next day. Refraining from dosing for two consecutive days returns individuals to their baseline state. Over time, microdosers may observe broader improvements in mood, focus, memory, and overall well-being, leading to a more engaged and present lifestyle.

The dosage mentioned, 125 mg / 250 mg / 75 mg, refers to the amount of magic mushrooms per capsule. It’s essential to be cautious when combining microdosing with stimulants such as coffee, energy drinks, and ADHD medications.

Magic mushrooms offer a multitude of benefits, motivating our commitment to their exploration. Here are some of the most extensively documented advantages:

• • Enhanced mood
  • Heightened focus
  • Increased creativity
  • Boosted energy levels
  • Facilitated flow states
  • Encouragement of pro-social behavior
  • Improved mental clarity
  • Enhanced empathy
  • Strengthened relational skills
  • Enhanced athletic coordination
  • Fostered leadership development
  • Improved social abilities

Magic mushrooms also exhibit the potential to mitigate the frequency and intensity of adverse feelings associated with various mental states, including:

• • Depression
  • Anxiety
  • Attention Deficit Disorder (ADD) / Attention Deficit Hyperactivity Disorder (ADHD)
  • Post-Traumatic Stress Disorder (PTSD)
  • Addiction
  • Psychosomatic issues

Microdosing is a widely practiced method, yet it carries legal implications. Explore the legal aspects in this article. However, concerning safety, microdosing has demonstrated remarkable safety. Studies affirm it as a secure treatment alternative. Delve deeper into this topic with additional reading. Moreover, for an in-depth understanding, explore the comprehensive findings of the 2019 Global Drug Survey, where mushroom-related discussions commence on page 93.

The term “flow state” refers to a mental state in which a person is fully immersed in a task, often described as being “in the zone”. It is characterized by intense focus and a sense of timelessness, where hours can pass by without the individual even realizing it. Have you ever been so absorbed in a project that you lost track of time? If so, you were most likely experiencing a flow state.

Studies have shown that psilocybin causes alpha oscillations in the brain, similar to those seen in flow states. Additionally, psilocybin encourages higher levels of serotonin, which are found during flow states.

Psychedelics can quiet the default mode network and enable unique connections between areas that don’t usually communicate, which is crucial for accessing flow states.

Anecdotal evidence suggests that adhering to a regular microdosing regimen can offer relief to individuals grappling with depression, anxiety, PTSD, ADD/ADHD, mood disorders, and/or addiction. Notable instances include:

In 2019, the Harm Reduction Journal published a study delving into the experiences of microdosers within a sample of 278 participants. Widely regarded as one of the most rigorous investigations on microdosing, this study provides empirical support for anecdotal reports of enhanced mood, focus, creativity, and more. We recommend delving into their findings for deeper insights [Microdosing – Wikipedia].

Additionally, numerous clinical research trials have demonstrated the efficacy of larger doses of psychedelics in treating conditions such as depression, end-of-life anxiety, and addiction.

Furthermore, integrating microdosing with psychotherapy (which we highly recommend) may facilitate more open dialogue about previously challenging topics. It may also unveil creative insights into one’s self, past experiences, and relationships, fostering avenues for personal growth.